CIK 0001819576
- Non-accelerated filer
Liquidia Corp
Sign in to watch- Ticker
- LQDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 851710962
- Phone
- +1 919-328-4400
- Business address
- 419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC, 27560
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $17,032,584
- in 16 filings, $9.5M under 10b5-1 plans
Net −$17,032,584. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-09 | Schundler Russell General Counsel | Exercise or conversion 10b5-1 | +25,636 | 606,683 | ||
| 2026-01-09 | Schundler Russell General Counsel | Exercise or conversion · Performance Stock Units 10b5-1 | −3,759 | 30,067 | ||
| 2026-01-09 | Schundler Russell General Counsel | Exercise or conversion · Performance Stock Units 10b5-1 | −25,636 | 76,907 | ||
| 2026-01-09 | JEFFS ROGER Chief Executive Officer | Exercise or conversion 10b5-1 | +13,833 | 1,046,806 | ||
| 2026-01-09 | JEFFS ROGER Chief Executive Officer | Exercise or conversion 10b5-1 | +57,332 | 1,104,138 | ||
| 2026-01-09 | JEFFS ROGER Chief Executive Officer | Exercise or conversion · Performance Stock Units 10b5-1 | −13,833 | 110,669 | ||
| 2026-01-09 | JEFFS ROGER Chief Executive Officer | Exercise or conversion · Performance Stock Units 10b5-1 | −57,332 | 171,995 | ||
| 2026-01-09 | Boyle Dana Chief Accounting Officer | Exercise or conversion 10b5-1 | +12,716 | 167,747 | ||
| 2026-01-09 | Boyle Dana Chief Accounting Officer | Exercise or conversion · Performance Stock Units 10b5-1 | −12,716 | 38,145 | ||
| 2026-01-09 | Saggar Rajeev Chief Medical Officer | Exercise or conversion 10b5-1 | +3,531 | 180,080 | ||
| 2026-01-09 | Saggar Rajeev Chief Medical Officer | Exercise or conversion 10b5-1 | +17,945 | 198,025 | ||
| 2026-01-09 | Saggar Rajeev Chief Medical Officer | Exercise or conversion · Performance Stock Units 10b5-1 | −3,531 | 28,246 | ||
| 2026-01-09 | Saggar Rajeev Chief Medical Officer | Exercise or conversion · Performance Stock Units 10b5-1 | −17,945 | 53,835 | ||
| 2025-12-01 | Schundler Russell General Counsel | Sale 10b5-1 | −1,072 | $32.19 | $35K | 577,288 |
| 2025-12-01 | Krepp Sarah Chief Human Resource Officer | Sale 10b5-1 | −221 | $32.19 | $7K | 141,218 |
| 2025-12-01 | Kaseta Michael CFO and COO | Sale 10b5-1 | −1,166 | $32.19 | $38K | 353,823 |
| 2025-12-01 | Boyle Dana Chief Accounting Officer | Sale 10b5-1 | −303 | $32.19 | $10K | 155,031 |
| 2025-12-01 | Adair Jason Chief Business Officer | Sale 10b5-1 | −693 | $32.19 | $22K | 175,868 |
| 2025-12-01 | Moomaw Scott Chief Commercial Officer | Sale 10b5-1 | −831 | $32.19 | $27K | 154,506 |
| 2025-11-28 | Schundler Russell General Counsel | Exercise or conversion 10b5-1 | +2,343 | 578,360 |
Page 19 of 29 · 579 trades